Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Dec-18 4:31 PM View:  | Cameron Kevin J Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 186,666 | -- | -- | (100%) 186.67K to 0 | |
| 13-Dec-18 4:35 PM View: | Heffernan Michael Thomas Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 20,000 | -- | -- | (100%) 20.0K to 0 | |
| 13-Dec-18 4:31 PM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 100,646 | -- | -- | (100%) 100.65K to 0 | |
| 13-Dec-18 4:36 PM View: | Regan Daniel Paul Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 60,000 | -- | -- | (100%) 60.0K to 0 | |
| 13-Dec-18 4:02 PM View: | Baupost Group Llc/ma Director 10% Owner | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 65,374,000 | -- | -- | (100%) 65.37M to 0 | |
| 13-Dec-18 4:37 PM View: | Morrison Jodie Pope Interim CEO Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 120,000 | -- | -- | (100%) 120.0K to 0 | |
| 13-Dec-18 4:33 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 148,279 | -- | -- | (100%) 148.28K to 0 | |
| 13-Dec-18 4:35 PM View: | Gilman Steven C Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 27,333 | -- | -- | (100%) 27.33K to 0 | |
| 13-Dec-18 4:39 PM View: | Enyedy Mark J Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 10,000 | -- | -- | (100%) 10.0K to 0 | |
| 13-Dec-18 4:37 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 162,956 | -- | -- | (100%) 162.96K to 0 | |
| 13-Dec-18 4:40 PM View: | Rogers Michael W Director | Keryx Biopharmaceuticals Inc. (KERX) | 12-Dec-18 | Disposition | 30,000 | -- | -- | (100%) 30.0K to 0 | |
| 13-Dec-18 4:31 PM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 11-Dec-18 | Market Sale | 10,469 | $3.22 | $33,710.20 | (9%) 111.11K to 100.65K | (4%) |
| 13-Dec-18 4:02 PM View: | Baupost Group Llc/ma Director 10% Owner | Keryx Biopharmaceuticals Inc. (KERX) | 11-Dec-18 | Grant | 39,582,300 | $4.16 | $164,746,000.00 | 153% 25.79M to 65.37M | |
| 16-Nov-18 8:49 AM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Nov-18 | Market Sale | 1,156 | $2.77 | $3,202.12 | (< 1%) 149.44K to 148.28K | (21%) |
| 16-Nov-18 8:49 AM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Nov-18 | Market Sale | 1,155 | $2.77 | $3,199.35 | (< 1%) 164.11K to 162.96K | (21%) |
| 30-Oct-18 4:07 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 29-Oct-18 | Market Sale | 1,254 | $3.07 | $3,849.78 | (< 1%) 165.37K to 164.11K | (9%) |
| 30-Oct-18 4:07 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 29-Oct-18 | Market Sale | 1,253 | $3.07 | $3,846.71 | (< 1%) 150.69K to 149.44K | (9%) |
| 22-Oct-18 8:50 AM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 18-Oct-18 | Market Sale | 2,040 | $3.29 | $6,711.60 | (2%) 113.16K to 111.11K | (2%) |
| 16-Aug-18 7:11 AM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Aug-18 | Market Sale | 1,185 | $3.04 | $3,602.40 | (< 1%) 166.55K to 165.37K | (11%) |
| 16-Aug-18 7:10 AM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Aug-18 | Market Sale | 1,186 | $3.04 | $3,605.44 | (< 1%) 151.87K to 150.69K | (11%) |
| 31-Jul-18 4:34 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jul-18 | Market Sale | 1,282 | $3.86 | $4,948.52 | (< 1%) 153.16K to 151.87K | 13% |
| 31-Jul-18 4:34 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jul-18 | Market Sale | 2,354 | $3.86 | $9,086.44 | (1%) 168.9K to 166.55K | 13% |
| 19-Jul-18 5:09 PM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 18-Jul-18 | Market Sale | 2,021 | $4.49 | $9,074.29 | (2%) 115.18K to 113.16K | 25% |
| 12-Jul-18 5:59 PM View: | Regan Daniel Paul Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 20% 50.0K to 60.0K | |
| 12-Jul-18 6:00 PM View: | Morrison Jodie Pope Interim CEO Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 9% 110.0K to 120.0K | |
| 12-Jul-18 6:01 PM View: | Gilman Steven C Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 58% 17.33K to 27.33K | |
| 12-Jul-18 6:00 PM View: | Enyedy Mark J Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 12-Jul-18 6:01 PM View: | Rogers Michael W Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 50% 20.0K to 30.0K | |
| 12-Jul-18 6:02 PM View: | Cameron Kevin J Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 6% 176.67K to 186.67K | |
| 12-Jul-18 5:59 PM View: | Heffernan Michael Thomas Director | Keryx Biopharmaceuticals Inc. (KERX) | 30-Jun-18 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 19-Jun-18 4:13 PM View: | Cameron Kevin J Director | Keryx Biopharmaceuticals Inc. (KERX) | 18-Jun-18 | Market Sale (Planned) | 1,667 | $4.98 | $8,301.66 | (< 1%) 178.33K to 176.67K | 33% |
| 18-Jun-18 6:39 PM View: | Cameron Kevin J Director | Keryx Biopharmaceuticals Inc. (KERX) | 15-Jun-18 | Option Exercise | 10,000 | $0.48 | $4,800.00 | 6% 168.33K to 178.33K | |
| 12-Jun-18 4:01 PM View: | Gilman Steven C Director | Keryx Biopharmaceuticals Inc. (KERX) | 11-Jun-18 | Market Sale (Planned) | 1,334 | $5.12 | $6,830.08 | (7%) 18.67K to 17.33K | 34% |
| 31-May-18 4:19 PM View: | Gilman Steven C Director | Keryx Biopharmaceuticals Inc. (KERX) | 29-May-18 | Market Sale (Planned) | 1,333 | $5.22 | $6,958.26 | (7%) 20.0K to 18.67K | 36% |
| 31-May-18 4:20 PM View: | Cameron Kevin J Director | Keryx Biopharmaceuticals Inc. (KERX) | 29-May-18 | Market Sale (Planned) | 1,667 | $5.22 | $8,701.74 | (< 1%) 170.0K to 168.33K | 36% |
| 16-May-18 4:40 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-May-18 | Market Sale | 1,158 | $5.69 | $6,589.02 | (< 1%) 170.06K to 168.9K | 41% |
| 16-May-18 4:40 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-May-18 | Market Sale | 1,158 | $5.69 | $6,589.02 | (< 1%) 154.31K to 153.16K | 41% |
| 14-May-18 9:52 PM View: | Morrison Jodie Pope Interim CEO Director | Keryx Biopharmaceuticals Inc. (KERX) | 10-May-18 | Grant | 100,000 | -- | -- | 1000% 10.0K to 110.0K | |
| 01-May-18 4:16 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 30-Apr-18 | Market Sale | 2,407 | $4.67 | $11,240.70 | (1%) 172.47K to 170.06K | 28% |
| 01-May-18 4:14 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 30-Apr-18 | Market Sale | 1,311 | $4.67 | $6,122.37 | (< 1%) 155.63K to 154.31K | 28% |
| 24-Apr-18 4:29 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 23-Apr-18 | Market Sale | 1,111 | $4.59 | $5,099.49 | (< 1%) 156.74K to 155.63K | 27% |
| 20-Apr-18 4:11 PM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 18-Apr-18 | Market Sale | 2,026 | $4.83 | $9,785.58 | (2%) 117.2K to 115.18K | 30% |
| 22-Mar-18 5:31 PM View: | Carberry Christine A. Chief Operating Officer | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 41,250 | -- | -- | 54% 75.95K to 117.2K | |
| 22-Mar-18 5:30 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 41,250 | -- | -- | 36% 115.49K to 156.74K | |
| 22-Mar-18 5:31 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 41,250 | -- | -- | 31% 131.22K to 172.47K | |
| 22-Mar-18 5:31 PM View: | Madison Greg President and CEO Director | Keryx Biopharmaceuticals Inc. (KERX) | 20-Mar-18 | Grant | 152,500 | -- | -- | 37% 414.09K to 566.59K | |
| 16-Feb-18 4:04 PM View: | Adams Brian General Counsel and Secretary | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 5,652 | $4.81 | $27,186.10 | (4%) 131.72K to 126.07K | 30% |
| 16-Feb-18 4:04 PM View: | Madison Greg President and CEO Director | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 15,318 | $4.81 | $73,679.60 | (4%) 429.4K to 414.09K | 30% |
| 16-Feb-18 4:05 PM View: | Holmes Scott A Chief Financial Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 5,651 | $4.81 | $27,181.30 | (4%) 136.87K to 131.22K | 30% |
| 16-Feb-18 4:04 PM View: | Neylan John F. Chief Medical Officer | Keryx Biopharmaceuticals Inc. (KERX) | 15-Feb-18 | Market Sale | 5,652 | $4.81 | $27,186.10 | (5%) 121.14K to 115.49K | 30% |
